US-based biopharmaceutical company Kadmon Holdings (Kadmon) has announced a public offering of common stock shares to raise up to $40m in total.

The company plans to use the funds towards clinical development of its product candidates and general corporate purposes.

Antares Pharma has announced plans to raise $30m through a public offering of its common stock shares.

"Antares Pharma has announced plans to raise $30m through a public offering of its common stock shares."

The US-based specialist pharmaceutical company plans to use the funds for general corporate purposes.

SK Capital has announced plans to acquire Perrigo API, the active pharmaceutical ingredients (API) business of Perrigo Company, for $110m.

SK Capital is a private investment firm based in the US, while Perrigo is an Irish healthcare company. The transaction will complement the existing businesses of SK Capital.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.